Results 61 to 70 of about 26,501 (228)

Microbiome and Tumor Microenvironment Interactions: Advances From Ecological Niches to Precision Oncology

open access: yesCancer Nexus, EarlyView.
Tumor‐associated microbiota occupies spatially organized ecological niches and influence cancer progression by reshaping tumor‐cell signaling, metabolism, immunity, stromal remodeling, and therapeutic response. Integrating microbiome‐derived biomarkers, targeted microbial interventions, spatial multi‐omics, longitudinal monitoring, and AI may enable ...
Yiwen Zhang   +7 more
wiley   +1 more source

Factors Predicting Survival after Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma

open access: yesMiddle East Journal of Cancer, 2014
Background: Transarterial chemoembolization is the preferred treatment for unresectable, intermediate-stage hepatocellular carcinoma. Survival after transarterial chemoembolization can be highly variable.
Farina M. Hanif   +5 more
doaj  

A case of spontaneous hepatic hemangioma rupture: Successful management with transarterial chemoembolization alone

open access: yesJournal of Interventional Medicine, 2019
Hemangioma is the most common benign hepatic tumor. Although spontaneous rupture is rare, the mortality rate ranges from 60 to 75%. Only 34 cases have been reported in the literature, with only one report using transcatheter arterial embolization (TAE ...
Yanyan Cao   +6 more
doaj   +1 more source

Micro/Nanostructured Materials and Microfluidic Diagnostic Platforms Enable Multimodal Detection of Circulating Tumor Cells

open access: yesExploration, EarlyView.
Engineered micro/nanomaterials enable high‐efficiency CTC capture, release, and multimodal molecular profiling. Integrated with AI‐driven analytics, these platforms decode tumor heterogeneity and metastatic dynamics, advancing real‐time monitoring and precision oncology through DNA, RNA, and protein cross‐scale data fusion.
Hao Li   +7 more
wiley   +1 more source

Repeated transarterial chemoembolization with epirubicin‑loaded superabsorbent polymer microspheres vs. conventional transarterial chemoembolization for hepatocellular carcinoma

open access: yesMolecular and Clinical Oncology, 2021
The aim of the present study was to evaluate the long-term outcomes and the impact of repeated conventional transarterial chemoembolization (C-TACE) and transarterial chemoembolization with epirubicin-loaded superabsorbent polymer embolics (SAP-TACE) on liver function in TACE-naïve patients with unresectable hepatocellular carcinoma (HCC). Overall, 155
Fukushima, Taito   +8 more
openaire   +3 more sources

Does Baking Soda Function as a Magic Bullet for Patients With Cancer? A Mini Review

open access: yesIntegrative Cancer Therapies, 2020
Sodium bicarbonate, commonly known as baking soda, is widely used in the clinic as an antacid for treating gastric hyperacidity, among other conditions.
Mengyuan Yang PhD   +2 more
doaj   +1 more source

Multi‐omics–driven precision medicine

open access: yesiMeta, EarlyView.
Multi‐omics‐driven precision medicine (MODPM) provides a multiscale, continuously learnable framework that integrates genomics, epigenomics, transcriptomics, proteomics, metabolomics, microbiome profiles, and clinical data. Powered by artificial intelligence and foundation models, MODPM enables cross‐modal representation learning, contextual modeling ...
Huibo Li   +20 more
wiley   +1 more source

CT-guided 125I brachytherapy for hepatocellular carcinoma in high-risk locations after transarterial chemoembolization combined with microwave ablation: a propensity score-matched study

open access: yesRadiology and Oncology, 2023
This study aimed to evaluate the safety and efficacy of 125I brachytherapy combined with transarterial chemoembolization (TACE) and microwave ablation (MWA) for unresectable hepatocellular carcinoma (HCC) in high-risk locations.
Chen Zixiong   +8 more
doaj   +1 more source

Interleukin‐37 Enhances Liver NK Cell Cytotoxicity and Improves Recurrence‐Free Survival in Hepatocellular Carcinoma Patients

open access: yesJournal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Introduction Hepatocellular carcinoma (HCC) remains a major cause of cancer‐related mortality worldwide, and postoperative recurrence continues to limit long‐term survival. Liver‐resident natural killer (NK) cells are key effectors of antitumor immunity in the hepatic microenvironment. Interleukin‐37 (IL‐37), an anti‐inflammatory cytokine, has
Yuki Imaoka   +10 more
wiley   +1 more source

Radioembolization Followed by Transarterial Chemoembolization in Hepatocellular Carcinoma

open access: yesCureus, 2022
In recent years, combination therapies for hepatocellular carcinoma (HCC) have been increasingly used with superior treatment responses compared to monotherapies. However, the safety and efficacy of the transarterial chemoembolization (TACE) and transarterial radioembolization (TARE) combinations for HCC patients have not been investigated in the ...
Vardar, Baran U   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy